Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides?

Alfredo J Mena LoraRodrigo BurgosScott A BorgettiLelia H ChaissonSusan C Bleasdale

Published in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2023)

COVID-19 therapies were challenging to deploy due to evolving literature and conflicting guidelines. Antimicrobial stewardship can help optimize drug use. We conducted a survey to understand the role of stewardship and formulary restrictions during the pandemic. Restrictions for COVID-19 therapies were common and approval by infectious disease physicians often required.

Keyphrases

coronavirus disease
sars cov
infectious diseases
respiratory syndrome coronavirus
primary care
systematic review
emergency department
drug induced
drug administration
adverse drug